Iliac Stent Market To Reach $1.53 Billion By 2030 | CAGR: 5.8%

Iliac Stent Market Growth & Trends

The globall iliac stent market size is expected to reach USD 1.53 billion by 2030, projected to grow at a CAGR of 5.8% from 2024 to 2030, based on a new report by Grand View Research, Inc. The market is expected to grow due to factors such as the increasing prevalence of peripheral artery diseases, growing advancements in medical technology, and expanding awareness about minimally invasive procedures as an effective treatment option for cardiovascular diseases.

The industry's growth is driven by new product development and aligned procedures with enhanced patency. For instance, self-expanding stents have demonstrated exceptional results in the treatment of external iliac artery. Furthermore, the growing prevalence of peripheral artery disease (PAD) is expected to propel iliac stents market growth. According to an article by the Institute for Health Metrics and Evaluation in October 2023, the global prevalence of PAD was pegged at 1.52% or nearly 113 million people. Additionally, NCBI's article in 2022 projected the annual incidence of PAD to be nearly 10 million. 

An increase in strategic initiatives amongst the key players of iliac stents is anticipated to propel growth. For instance, in January 2024, Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval from the National Medical Products Administration (NMPA) for its peripheral venous stent system. Furthermore, in October 2023, Getinge AB announced the commercial availability of its product, iCast covered stent system to treat iliac arterial occlusive disease in the U.S.

 Request a free sample copy or view report summary: Iliac Stent Materials Market Report

Iliac Stents Market Report Highlights

• The iliac stents marketin the healthcare industry was estimated at USD 1.03 Billion in 2023 and is expected to reach USD 1.53 Billion in 2030

• The iliac stents marketis expected to grow at a compound annual growth rate of 5.8% from 2024 to 2030 to reach USD 1.53 Billion by 2030

• In 2023, North America held the largest share in the iliac stents market, with a revenue share of 43.7%. The growing geriatric population in the U.S., which is susceptible to PAD is expected to increase the demand for stenting procedures, thereby significantly contributing to the market growth over the forecast period

• By type, self-expandable stents segment accounted for the largest revenue share of 60.4% in 2023driven by favorable long-term clinical study results for these stents that are expected to instill confidence in healthcare providers

• By artery lesions, the common iliac artery lesions segment accounted for the largest revenue share of 60.5% in 2023 driven by growing cases of patients suffering from high cholesterol and obesity are expected to boost the demand for iliac stents, as these conditions cause plaque buildup, which narrows or blocks artery lumen

• By end use, hospital segment accounted for a dominant revenue share of 61.7% in 2023. Hospitals serve as referral centers where patients receive comprehensive care, including diagnostic imaging, medical management, and interventional procedures like iliac stent placement

Iliac Stents Market Segmentation

Grand View Research has segmented the global iliac stents market based on type, artery lesions, end-use, and region:

Iliac Stents Type Outlook (Revenue, USD Million, 2018 - 2030)

• Self-expandable Stents

• Balloon-expandable Stents

• Others

Iliac Stents Artery Lesions Outlook (Revenue, USD Million, 2018 - 2030)

• Common Iliac Artery Lesions

• Severe Calcified Lesions

• Complete Obstructive Lesions

Iliac Stents End-Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Outpatient Facilities

• Others

Iliac Stents Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Iliac Stent Market

• BD

• Abbott

• Boston Scientific Corporation

• W. L. Gore & Associates, Inc.

• Medtronic

• Cook

• Terumo Corporation

• iVascular

• Getinge AB

• Biotronik SE & Co KG